<DOC>
	<DOCNO>NCT00207220</DOCNO>
	<brief_summary>This study test hypothesis increase ventricular-vascular stiffness demonstrate arterial tonometry echocardiography subject heart failure preserve ejection fraction ( HF-nlEF ) ( i.e . normal leave ventricular function . ) We also track change pulsatile hemodynamics time subject hospitalize HF-nlEF .</brief_summary>
	<brief_title>Ventricular-Vascular Coupling Heart Failure</brief_title>
	<detailed_description>The pathophysiologic mechanism responsible development heart failure people preserve ejection fraction ( i.e . normal leave ventricular function ) remain poorly understood . One possible mechanism may contribution increase arterial stiffness change pulsatile hemodynamic load ventricular systole , implicate abnormal ventricular-vascular interaction throughout cardiac cycle pathogenesis heart failure normal ejection fraction . To investigate change ventricular-vascular stiffness subject heart failure normal leave ventricular function , comparison make 3 distinct sub-populations : - subject heart failure normal ejection fraction - non-diabetic hypertensive control - normotensive control</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subjects heart failure preserve ejection fraction clinical sign heart failure serum brain natriuretic peptide ( BNP ) &gt; 100pg/mL NYHA functional class IIIV leave ventricular ejection fraction ( LVEF ) &gt; =50 % measure echocardiography Nondiabetic subject hypertension treat untreated essential hypertension LVEF &gt; =50 % measure echocardiography Diabetic subject hypertension Type 2 diabetes treat untreated essential hypertension LVEF &gt; =50 % measure echocardiography Normotensive control subject normal blood pressure ( i.e . &lt; 140/90 mmHg ) LVEF &gt; =50 % measure echocardiography Subjects heart failure preserve ejection fraction atrial fibrillation symptom angina myocardial infarction ( MI ) within 6 month know significant coronary artery disease ( CAD ) ( stenosis &gt; 70 % ) significant valvular heart disease restrictive/constrictive heart disease inability lie flat procedure ( estimate duration 1 hour ) Nondiabetic subject hypertension atrial fibrillation symptom angina myocardial infarction ( MI ) within 6 month know significant coronary artery disease ( CAD ) ( stenosis &gt; 70 % ) significant valvular heart disease restrictive/constrictive heart disease inability lie flat procedure ( estimate duration 1 hour ) prior history heart failure unexplained dyspnea Diabetic subject hypertension atrial fibrillation symptom angina myocardial infarction ( MI ) within 6 month know significant coronary artery disease ( CAD ) ( stenosis &gt; 70 % ) significant valvular heart disease restrictive/constrictive heart disease inability lie flat procedure ( estimate duration 1 hour ) prior history heart failure unexplained dyspnea Normotensive control subject prior history structural heart disease ventricular hypertrophy treatment HMGCo ( A ) reductase inhibitor ( statin ) antihypertensive medication cigarette smoke cocaine use excessive alcohol intake</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>heart failure</keyword>
	<keyword>preserve ejection fraction</keyword>
	<keyword>vascular stiffness</keyword>
</DOC>